Susceptibility alleles for aberrant B-1 cell proliferation involved in spontaneously occurring B-cell chronic lymphocytic leukemia in a model of New Zealand white mice

Blood

Volumn 92, Issue 10, 1998, Pages 3772-3779

  Hamano, Yoshitomo ^b   Hirose, Sachiko ^b   Ida, Akinori ^b   Abe, Masaaki ^b   Zhang, Danqing ^b   Kodera, Sanki ^b   Jiang, Yi ^b   Shirai, Jun ^b   Miura, Yuko ^b   Nishimura, Hiroyuki ^b   Shirai, Toshikazu ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CHROMOSOME 13; CHROMOSOME 17; CHRONIC LYMPHATIC LEUKEMIA; DISEASE PREDISPOSITION; FEMALE; FLOW CYTOMETRY; GENE; GENE MAPPING; HETEROZYGOSITY; HOMOZYGOSITY; LEUKEMOGENESIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032533607     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3772     Document Type: Article

References (66)

1. Cuttner J: Increased incidence of hematologic malignancies in first-degree relatives of patients with chronic lymphocytic leukemia. Cancer Invest 10:103, 1992
2. Haenszel W, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43, 1968
3. Cronkite EP: An historical account of clinical investigations on chronic lymphocytic leukemia in the Medical Research Center, Brookhaven National Laboratry. Blood Cells 12:285, 1987
4. Yanagihara ET, Blaisdell RK, Hayashi T, Lukes RJ: Malignant lymphoma in Hawaii-Japanese: A retrospective morphologic survey. Hematol Oncol 7:219, 1989
5. Arif M, Tanaka K, Asou H, Ohno R, Kamada N: Independent clones of trisomy 12 and retinoblastoma gene deletion in Japanese B cell chronic lymphocytic leukemia, detected by fluorescence in situ hybridization. Leukemia 9:1822, 1995
6. Hamblin TJ, Oscier DG, Young BJ: Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol 39:713, 1986
7. Ebbe S, Wittels B, Dameshek W: Autoimmune thrombocytopenic purpura ("ITP type") with chronic lymphocytic leukemia. Blood 19:23, 1962
8. Zulman J, Ronald J, Talal N: Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med 299:1215, 1978
9. Green JA, Dawson AA, Walker W: Systemic lupus erythematosus and lymphoma. Lancet 2:753, 1978
10. Mason RW: S.L.E. and lymphoma. Lancet 1:156, 1979
11. Pirofsky B: Clinical aspects of autoimmune hemolytic anemia. Semin Hematol 13:251, 1976
12. Conley CL, Misiti J, Laster AJ: Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine 59:323, 1980
13. Caligaris-Cappio F: B-chronic lymphocytic leukemia: A malignancy of anti-self B cells. Blood 87:2615, 1996
14. + B cells in autoimmune disease and in chronic lymphocytic leukemia. Ann N Y Acad Sci 651:509, 1992
15. + B-cell subset. Science 236:77, 1987
16. Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T: Rheumatoid factor secretion from human Leu-1 B cells. Science 236:81, 1987
17. Okada T, Abe M, Takiura F, Hirose S, Sato H, Shirai T: Distinct surface phenotypes of B cells responsible for spontaneous production of IgM and IgG anti-DNA antibodies in autoimmune-prone NZB × NZW F1 mice. Autoimmunity 7:109, 1990
18. Sthoeger ZM, Wakai M, Tse DB, Vinciguerra VP, Allen SL, Budman DR, Lichtman SM, Schulman P, Weiselberg LR, Chiorazzi N: Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med 169:255, 1989
19. Borche L, Annick L, Binet JL, Dighiero G: Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 76:562, 1990
20. Kipps TJ, Carson CA: Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 81:2475, 1993
21. Kipps TJ, Tomhave E, Pratt LF, Duffy S, Chen PP, Carson DA: Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 86:5913, 1989
22. H5 genes used in common B cell chronic lymphocytic leukemia. J Exp Med 177:1039, 1993
23. + Ly-1 B clones of (NZB × NZW) F1 mice. EMBO J 7:3705, 1988
24. Forster I, Gu H, Rajewsky K: Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. EMBO J 7:3693, 1988
25. Kipps TJ, Robbins BA, Kuster P, Carson DA: Autoantibody- associated cross-reactive idiotypes expressed at high frequency in chronic lymphocytic leukemia relative to B-cell lymphomas of follicular center cell origin. Blood 72:422, 1988
26. Caligaris-Cappio F, Gobbi M, Bofill M, Janossy G: Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 155:623, 1982
27. +) B cells. A major lymphoid subpopulation in human fetal spleen: Phenotypic and functional studies. J Immunol 136:505, 1986
28. Herzenberg LA, Kantor AB, Herzenberg LA: Layered evoluton in the immune system. A model for the ontogeny and development of multiple lymphocyte lineages. Ann N Y Acad Sci 651:1, 1992
29. Hayakawa K, Hardy RR, Honda M, Herzenberg LA, Steinberg AD, Herzenberg LA: Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 81:2494, 1984
30. + B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 10:364, 1989
31. Hirose S, Yan K, Abe M, Jiang Y, Hamano Y, Tsurui H, Shirai T: Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination. Proc Natl Acad Sci USA 94:9291, 1997
32. Taki S, Hirose S, Kinoshita K, Nishimura H, Shimamura T, Hamuro J, Shirai T: Somatically mutated IgG anti-DNA antibody clonally related to germ-line encoded IgM anti-DNA antibody. Eur J Immunol 22:987, 1992
33. Hirose S, Wakiya M, Kawano-Nishi Y, Jiang Y, Sanokawa R, Taki S, Shimamura T, Kishimoto T, Tsurui H, Nishimura H, Shirai T: Somatic diversification and affinity maturation of IgM and IgG anti-DNA antibodies in murine lupus. Eur J Immunol 23:2813, 1993
34. Hirose S, Ueda G, Noguchi K, Okada T, Sekigawa I, Sato H, Shirai T: Requirement of H-2 heterozygosity for autoimmunity in (NZB × NZW) F1 hybrid mice. Eur J Immunol 16:1631, 1986
35. Hirose S, Kinoshita K, Nozawa S, Nishimura H, Shirai T: Effects of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand mice. Int Immunol 2:1091, 1990
36. + B cells in H-2-congenic New Zealand mice: A model for B cell chronic lymphocytic leukemia and autoimmune disease. Eur J Immunol 21:2743, 1991
37. Z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: Elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages. Jpn J Cancer Res 84:1273, 1993
38. Figueroa F, Tewarson S, Neufeld E, Klein J: H-2 haplotypes of strains DBR7, B10.NZW, NFS, BQ2, STU, TO1, and T02. Immunogenetics 15:431, 1982
39. Dietrich W, Katz H, Lincoln SE, Shin HS, Friedman J, Dracopoli NC, Lander ES: A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131:423, 1992
40. Lander ES, Green P, Abrahamson J, Barlow A, Daly MJ, Lincoln SE, Newburg L: MAPMAKER: An interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1:174, 1987
41. Lander E, Kruglyak L: Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11:241, 1995
42. Lander E, Botstein D: Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121:185, 1989
43. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C, The French-American-British (FAB) Cooperative Group: Proposal for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 42:567, 1989
44. Kono DH, Burlingame RS, Owens D, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN: Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 91:10168, 1994
45. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK: Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219, 1994
46. Drake CG, Babcock SK, Palmer E, Kotzin BL: Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW)F1 mice. Proc Natl Acad Sci USA 91:4062, 1994
47. d class II molecule in (NZB × NZW) F1 mice detected by T cell clones. J Immunol 150:4777, 1993
48. + T-cell clones. Immunology 83:221, 1994
49. Mueller U, Jongeneel CV, Nedospasov SA, Lindahl KF, Steinmetz M: Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex. Nature 325:265, 1987
50. Trentin L, Zambello R, Agostini C, Siviero F, Adami F, Marcolongo R, Raimondi R, Chisesi T, Pizzolo G, Semenzato G: Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood 81:752, 1993
51. Trentin L, Zambello R, Agostini C, Enthammer C, Cerutti A, Adami F, Zamboni S, Semenzato G: Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia. Blood 84:4249, 1994
52. Adami F, Guarini A, Pini F, Siviero F, Sancetta R, Massaia M, Trentin L, Foa R, Semenzato G: Serum levels of tumor necrosis factor-α in patients with B-cell chronic lymphocytic leukemia. Eur J Cancer 30A:1259, 1994
53. Jacob CO, McDevitt HO: Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis. Nature 331:356, 1988
54. Fujimura T, Hirose S, Jiang Y, Kodera S, Ohmuro H, Zhang D, Hamano Y, Ishida H, Furukawa S, Shirai T: Dissection of the effects of tumor necrosis factor-α and class II gene polymorphisms within the major histocompatibility complex on murine systemic lupus erythematosus. Int Immunol (in press)
55. Yamashita T, Takahashi S, Ogata E: Expression of activin A/erythroid differentiation factors in murine bone marrow stromal cells. Blood 79:304, 1992
56. Yamashita T, Shimizu T, Ogata E: Activin A/erythroid differentiation factor induces thromboxane A: synthetic activity in murine erythroleukemia cells. J Biol Chem 266:3888, 1991
57. Hashimoto M, Shoda A, Inoue S, Yamada R, Kondo T, Sakurai T, Ueno N, Muramatsu M: Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin. J Biol Chem 267:4999, 1992
58. From web site of National Center for Biotechnology Information. (http://www.ncbi.nlm.nih.gov/)
59. Barlow DP, Stoeger R, Herrmann BG, Saito K, Schweifer N: The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349:84, 1991
60. De Souza AT, Yamada T, Mills JJ, Jirtle RL: Imprinted genes in liver carcinogenesis. FASEB J 11:60, 1997
61. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle RL: M6P/IGF2 receptor: A candidate breast tumor suppressor gene. Oncogene 12:2003, 1996
62. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, Neely K, Hintz R: Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 269:13779, 1994
63. Raveché, ES: Possible immunoregulatory role for CD5+ B cells. Clin Immunol Immunopathol 56:135, 1990
64. Phillips JA, Mehta K, Fernandez C, Raveche ES: The NZB mouse as a model for chronic lymphocytic leukemia. Cancer Res 52:437, 1992
65. Hirose S, Tsurui H, Nishimura H, Jiang Y, Shirai T: Mapping of a gene for hypergammaglobulinemia to the distal region on chromosome 4 in NZB mice and its contribution to systemic lupus erythematosus in (NZB × NZW) F1 mice. Int Immunol 6:1857, 1994
66. Jiang Y, Hirose S, Hamano Y, Kodera S, Tsurui H, Abe M, Terashima K, Ishikawa S, Shirai T: Mapping of a gene for the increased susceptibility of B1 cells to Mott cell formation in murine autoimmune disease. J Immunol 158:992, 1997